Track topics on Twitter Track topics that are important to you
The decision, which precedes final verdicts in the US and Europe, where review is currently ongoing, was based on Phase 3 data from two studies encompassing 7,180 postmenopausal women and 245 men with osteoporosis, finding the drug to be both safe and effective following a robust review.
Original Article: Amgen and UCB's Evenity approved in Japan for osteoporosisNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...